Deprescribing Information Pamphlets

EMPOWER Brochures are educational materials, developed by Dr. Tannebaum’s research team in Montreal. The brochures explain why it might be important to stop certain medications. When required, the brochures provide a step-wise tapering protocol.

• Sedative-hypnotic brochure
• Proton pump inhibitor brochure
• Sulfonylurea brochure
• Antipsychotic brochure
• Antihistamine brochure
• Opioid/narcotics brochure
• Non-steroidal anti-inflammatory drugs or NSAIDs

Proton Pump Inhibitor (PPI) Patient Decision Aid

As part of his post-graduate work with the Bruyère Research Institute, Dr. Wade Thompson developed a consult patient decision aid based on the proton pump inhibitor deprescribing guideline. Developed by the Bruyère Deprescribing Guidelines led team of health care and research experts, the evidence-based guidelines are products of quality research and real-world application.

Publications

Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre L. Continuation or deprescribing of proton pump inhibitors: a consult patient decision aid. Canadian Pharmacists Journal December 2018 (available online ahead of publication: https://doi.org/10/1177/1715163518816719.
Thompson W, Farrell B, Welch V, Tugwell P, Bjerre LM. Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid. Canadian Pharmacists Journal 2017;150(1):19-23. https://doi.org/10.1177/1715163516679425

Deprescribing Pamphlets align with each of the Bruyère evidence-based deprescribing guidelines and algorithms to provide lay-level information to help patients and caregivers have conversations with their prescribers about safe deprescribing.

• Proton pump inhibitor deprescribing guideline information pamphlet
• Benzodiazepine and Z-Drug deprescribing guideline information pamphlet
• Antihyperglycemic deprescribing guideline information pamphlet
• Antipsychotic deprescribing guideline information pamphlet